Income Statement OneMedNet Corporation NYSE

Stocks

ONMD

US68270C1036

Business Support Services

Market Closed - NYSE 01:30:00 19/09/2026 am IST			5-day change	1st Jan Change
0.7000 ^USD	+14.57%		-8.33%	-90.98%

01/09	OneMedNet Corporation Delivers Full-Fidelity Clinical Real-World Data To AI-Driven Drug Development Company	CI
15/08	OneMedNet Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

f41993226e9.yuusZRbCc0uFTC0umRCDPffaj595XV1O35ryWmgPq_E.qNLoK071GgHKDX1s1F36aMeK5s0SMxgLqNu0CTlQ-ZSC2u0yc_QEA9cuaA

Published financial data: ONEMEDNET CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	10.92L	11.53L	10.22L	6L	13.59L
Total Revenues	10.92L	11.53L	10.22L	6L	13.59L
Cost of Goods Sold, Total	12.05L	15.13L	11.5L	9L	18.62L
Gross Profit	-1L	-4L	-1L	-3L	-5L
Selling General & Admin Expenses, Total	19.54L	48.03L	66.15L	78.57L	76.49L
R&D Expenses	6L	10L	16.32L	14.67L	15.15L
Other Operating Expenses, Total	25.97L	57.55L	82.46L	93.24L	91.64L
Operating Income	-27.11L	-61.16L	-83.74L	-96.05L	-96.67L
Interest Expense, Total	-2L	-4L	-7L	-1L	-67T
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-2L	-4L	-7L	-1L	-67T
Other Non Operating Income (Expenses)	-34.9T	-46.82T	-35.78L	-4L	14.06L
EBT, Excl. Unusual Items	-29.41L	-65.66L	-1.27Cr	-1.01Cr	-83.28L
Asset Writedown	-	-	-1.05Cr	-	-
Other Unusual Items	-	-	-	-	55.28L
EBT, Incl. Unusual Items	-29.41L	-65.66L	-2.32Cr	-1.01Cr	-28L
Income Tax Expense	-	-	-	2T	1T
Earnings From Continuing Operations	-29.41L	-65.66L	-2.32Cr	-1.01Cr	-28.01L
Net Income to Company	-29.41L	-65.66L	-2.32Cr	-1.01Cr	-28.01L
Net Income - (IS)	-29.41L	-65.66L	-2.32Cr	-1.01Cr	-28.01L
Net Income to Common Incl Extra Items	-29.41L	-65.66L	-2.32Cr	-1.01Cr	-28.01L
Net Income to Common Excl. Extra Items	-29.41L	-65.66L	-2.32Cr	-1.01Cr	-28.01L
Per Share Items
Net EPS - Basic	-0.2	-1.44	-0.98	-0.36	-0.06
Basic EPS - Continuing Operations	-0.2	-1.44	-0.98	-0.36	-0.06
Basic Weighted Average Shares Outstanding	1.5Cr	45.6L	2.36Cr	2.81Cr	4.45Cr
Net EPS - Diluted	-0.2	-1.44	-0.98	-0.36	-0.06
Diluted EPS - Continuing Operations	-0.2	-1.44	-0.98	-0.36	-0.06
Diluted Weighted Average Shares Outstanding	1.5Cr	45.6L	2.36Cr	2.81Cr	4.45Cr
Normalized Basic EPS	-0.12	-0.9	-0.34	-0.23	-0.12
Normalized Diluted EPS	-0.12	-0.9	-0.34	-0.23	-0.12
Supplemental Items
EBITDA	-26.96L	-60.91L	-83.46L	-95.48L	-96.02L
EBITA	-27.11L	-61.16L	-83.74L	-96.05L	-96.67L
EBIT	-27.11L	-61.16L	-83.74L	-96.05L	-96.67L
Total Revenues (As Reported)	-	-	-	6L	13.59L
Effective Tax Rate - (Ratio)	-	-	-	-0.02	-0.04
Normalized Net Income	-18.38L	-41.04L	-79.38L	-63.29L	-52.05L
Supplemental Operating Expense Items
Selling and Marketing Expenses	6L	10L	11.15L	8L	12.72L
General and Administrative Expenses	11.97L	34.46L	52.74L	70.27L	63.77L
Research And Development Expense From Footnotes	6L	10L	16.32L	14.67L	15.15L
Stock-Based Comp., COGS (Total)	-	-	-	-	55T
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	1L
Stock-Based Comp., S&M Exp. (Total)	-	-	-	-	75T
Stock-Based Comp., G&A Exp. (Total)	-	15.92L	-	-	17.87L
Stock-Based Comp., Other (Total)	97.87T	7.71T	-	1.47Cr	-
Total Stock-Based Compensation	97.87T	16L	-	1.47Cr	20.32L

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	7L	3L	47.01T	2L	6L
Total Cash And Short Term Investments	7L	3L	47.01T	2L	6L
Accounts Receivable, Total	91.74T	18.98T	2L	2L	5L
Other Receivables	-	9L	-	-	-
Total Receivables	91.74T	9L	2L	2L	5L
Prepaid Expenses	42.23T	1L	2L	4L	5L
Other Current Assets, Total	-	-	-	28.49L	5L
Total Current Assets	8L	12.91L	4L	36.19L	20.95L
Gross Property Plant And Equipment	2L	3L	3L	3L	3L
Accumulated Depreciation	-2L	-2L	-2L	-2L	-3L
Net Property Plant And Equipment	49.77T	83.1T	98.87T	1L	56T
Total Assets	9L	13.74L	5L	37.27L	21.51L
Liabilities
Accounts Payable, Total	8L	11.35L	41.84L	63.71L	-
Accrued Expenses, Total	-	-	1L	-	34.96L
Short-term Borrowings	-	-	45.92L	87.63L	8L
Current Portion of Long-Term Debt	33.5L	84.9L	44.67T	-	-
Current Income Taxes Payable	-	-	1L	-	-
Unearned Revenue Current, Total	6L	2L	3L	6L	4L
Other Current Liabilities	-	-	35.25L	35.33L	2L
Total Current Liabilities	47.51L	98.08L	1.28Cr	1.92Cr	48.25L
Long-Term Debt	15.47L	15.44L	5L	-	2L
Other Non Current Liabilities	3L	7L	24.58T	4L	71T
Total Liabilities	65.86L	1.2Cr	1.33Cr	1.97Cr	51.16L
Preferred Stock Convertible	705	705	-	-	-
Total Preferred Equity	705	705	-	-	-
Common Stock, Total	434	455	2.36T	2T	2T
Additional Paid In Capital	1.96Cr	2.12Cr	4.22Cr	8.61Cr	10Cr
Retained Earnings	-2.53Cr	-3.19Cr	-5.51Cr	-10Cr	-10Cr
Treasury Stock	-	-	-	-5L	-5L
Total Common Equity	-57.03L	-1.07Cr	-1.29Cr	-1.6Cr	-29.65L
Total Equity	-57.03L	-1.07Cr	-1.29Cr	-1.6Cr	-29.65L
Total Liabilities And Equity	9L	13.74L	5L	37.27L	21.51L
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.5Cr	75.7L	2.39Cr	3.08Cr	5.22Cr
ECS Total Common Shares Outstanding	1.5Cr	75.7L	2.36Cr	2.8Cr	5.2Cr
Book Value / Share	-0.38	-1.41	-0.55	-0.57	-0.06
Tangible Book Value	-57.03L	-1.07Cr	-1.29Cr	-1.6Cr	-29.65L
Tangible Book Value Per Share	-0.38	-1.41	-0.55	-0.57	-0.06
Total Debt	48.97L	1Cr	51.01L	87.63L	10L
Net Debt	41.98L	97.63L	50.54L	85.91L	4L
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	2L	3L	3L	3L	3L
Full Time Employees	12	12	20	21	22
Part Time Employees	-	-	-	1	1
Accumulated Allowance for Doubtful Accounts (Supple)	22.53T	1L	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-29.41L	-65.66L	-2.32Cr	-1.01Cr	-28.01L
Depreciation & Amortization - CF	14.47T	24.81T	27.98T	57T	65T
Depreciation & Amortization, Total	14.47T	24.81T	27.98T	57T	65T
Asset Writedown & Restructuring Costs	-	-	-	-	-55.69L
Stock-Based Compensation (CF)	97.87T	16L	-	6L	20.32L
Other Operating Activities, Total	-	-	9L	10L	-13.36L
Change In Accounts Receivable	81.09T	-52.47T	-1L	-61T	-3L
Change In Accounts Payable	4L	4L	13.7L	14.93L	4L
Change in Unearned Revenues	5L	-5L	70.31T	3L	-2L
Change In Income Taxes	-	-	-94.83T	-	-
Change in Other Net Operating Assets	-631	-8L	2.93Cr	-2L	2L
Cash from Operations	-18.44L	-59.11L	82.21L	-69.83L	-75.03L
Capital Expenditure	-29.94T	-58.14T	-43.76T	-51T	-13T
Other Investing Activities, Total	-	-	-	-19.31L	23.2L
Cash from Investing	-29.94T	-58.14T	-43.76T	-19.82L	23.07L
Short Term Debt Issued, Total	-	-	15.5L	38.5L	-
Long-Term Debt Issued, Total	24.94L	55.43L	5L	-	-
Total Debt Issued	24.94L	55.43L	20.15L	38.5L	-
Short Term Debt Repaid, Total	-	-	-	-7L	-3L
Long-Term Debt Repaid, Total	-	-2.75T	-1.07Cr	-30T	-4L
Total Debt Repaid	-	-2.75T	-1.07Cr	-7L	-7L
Issuance of Common Stock	-	-	1.82Cr	62.7L	42.54L
Repurchase of Common Stock	-	-	-2.88Cr	-2L	-
Other Financing Activities, Total	-	-	1.08Cr	-1L	20.18L
Cash from Financing	24.94L	55.4L	-84.32L	90.9L	56.09L
Miscellaneous Cash Flow Adjustments	-	-1	-	-	-
Net Change in Cash	6L	-4L	-3L	1L	4L
Supplemental Items
Cash Interest Paid	-	-	-	26T	23T
Cash Income Tax Paid (Refund)	-	-	-	18T	1T
Levered Free Cash Flow	-7L	-34.77L	2.89Cr	71.78L	-78.41L
Unlevered Free Cash Flow	-6L	-32.25L	2.94Cr	72.7L	-77.99L
Change In Net Working Capital	-10L	10L	-3.46Cr	14.08L	38.41L
Net Debt Issued / Repaid	24.94L	55.4L	-86.65L	31.2L	-7L

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-279.79	-338.72	-33.88	-286.48	-205.58
Return on Total Capital	317.11	530.59	-73.13	77.29	141.13
Return On Equity %	68.69	80.21	1.29T	68.92	29.62
Return on Common Equity	68.68	80.21	1.29T	68.92	29.62
Margin Analysis
Gross Profit Margin %	-10.39	-31.29	-12.52	-43.7	-37.01
SG&A Margin	179.01	416.64	647.46	1.22T	562.84
EBITDA Margin %	-246.95	-528.43	-816.94	-1.48T	-706.55
EBITA Margin %	-248.27	-530.58	-819.68	-1.49T	-711.33
EBIT Margin %	-248.27	-530.58	-819.68	-1.49T	-711.33
Income From Continuing Operations Margin %	-269.36	-569.63	-2.27T	-1.58T	-206.11
Net Income Margin %	-269.36	-569.63	-2.27T	-1.58T	-206.11
Net Avail. For Common Margin %	-269.36	-569.63	-2.27T	-1.58T	-206.11
Normalized Net Income Margin	-168.35	-356.02	-777	-984.35	-383
Levered Free Cash Flow Margin	-68.67	-301.65	2.83T	1.12T	-576.95
Unlevered Free Cash Flow Margin	-57.48	-279.78	2.88T	1.13T	-573.87
Asset Turnover
Asset Turnover	1.8	1.02	0.07	0.31	0.46
Fixed Assets Turnover	25.97	17.35	11.23	6.21	16.57
Receivables Turnover (Average Receivables)	7.61	20.82	11.98	3.52	3.84
Short Term Liquidity
Current Ratio	0.18	0.13	0.03	0.19	0.43
Quick Ratio	0.17	0.12	0.02	0.02	0.22
Operating Cash Flow to Current Liabilities	-0.39	-0.6	0.64	-0.36	-1.56
Days Sales Outstanding (Average Receivables)	47.99	17.53	30.48	103.88	95.08
Average Days Payable Outstanding	174.13	228.34	1.11T	2.19T	-
Long Term Solvency
Total Debt/Equity	-85.87	-94.05	-39.67	-54.94	-32.85
Total Debt / Total Capital	-607.77	-1.58T	-65.75	-121.93	-48.92
LT Debt/Equity	-27.13	-14.47	-3.62	-	-7.42
Long-Term Debt / Total Capital	-191.99	-243.1	-5.99	-	-11.05
Total Liabilities / Total Assets	745.78	876.5	2.88T	527.96	237.84
EBIT / Interest Expense	-13.87	-15.17	-11.18	-65.34	-144.28
EBITDA / Interest Expense	-13.8	-15.1	-11.14	-64.95	-143.31
(EBITDA - Capex) / Interest Expense	-13.95	-15.25	-11.2	-65.3	-143.51
Total Debt / EBITDA	-1.82	-1.65	-0.61	-0.92	-0.1
Net Debt / EBITDA	-1.56	-1.6	-0.61	-0.9	-0.04
Total Debt / (EBITDA - Capex)	-1.8	-1.63	-0.61	-0.91	-0.1
Net Debt / (EBITDA - Capex)	-1.54	-1.59	-0.6	-0.89	-0.04
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	32.49	5.58	-11.37	-37.02	111.35
Gross Profit, 1 Yr. Growth %	-153.4	218.05	-64.54	117.83	79
EBITDA, 1 Yr. Growth %	-7.61	125.93	-26.79	39.9	0.57
EBITA, 1 Yr. Growth %	-7.56	125.64	-26.71	40.16	0.65
EBIT, 1 Yr. Growth %	-7.56	125.64	-26.71	40.16	0.65
Earnings From Cont. Operations, 1 Yr. Growth %	4.23	123.28	272.5	-70.01	-72.35
Net Income, 1 Yr. Growth %	4.23	123.28	272.5	-70.01	-72.35
Normalized Net Income, 1 Yr. Growth %	-3.77	123.28	71.95	-70	-17.76
Diluted EPS Before Extra, 1 Yr. Growth %	-	111.76	-27.94	-92.23	-82.57
Accounts Receivable, 1 Yr. Growth %	-53.04	-79.32	699.16	40.13	132.39
Net Property, Plant and Equip., 1 Yr. Growth %	45.11	66.97	18.98	9.09	-48.15
Total Assets, 1 Yr. Growth %	169.3	55.6	-98.48	703.23	-42.29
Tangible Book Value, 1 Yr. Growth %	99.39	87.08	-238.67	18.66	-81.41
Common Equity, 1 Yr. Growth %	99.39	87.08	-238.67	18.66	-81.41
Cash From Operations, 1 Yr. Growth %	-13.21	220.47	-90.58	45.75	7.93
Capital Expenditures, 1 Yr. Growth %	-	94.2	-24.73	15.91	-74.51
Levered Free Cash Flow, 1 Yr. Growth %	-	363.82	-185.43	-77.22	4.75
Unlevered Free Cash Flow, 1 Yr. Growth %	-	413.91	-187.47	-76.94	5.49
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	18.27	-3.26	-25.31	15.37
Gross Profit, 2 Yr. CAGR %	-	30.32	6.2	-11.74	97.46
EBITDA, 2 Yr. CAGR %	-	44.48	75.94	-8.49	18.61
EBITA, 2 Yr. CAGR %	-	44.43	75.77	-8.31	18.77
EBIT, 2 Yr. CAGR %	-	44.43	75.77	-8.31	18.77
Earnings From Cont. Operations, 2 Yr. CAGR %	-	52.55	180.9	27.51	-71.2
Net Income, 2 Yr. CAGR %	-	52.55	180.9	27.51	-71.2
Normalized Net Income, 2 Yr. CAGR %	-	46.58	107.82	17.09	-50.33
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	20.32	-48.61	-88.37
Accounts Receivable, 2 Yr. CAGR %	-	-68.84	28.56	235.04	80.46
Net Property, Plant and Equip., 2 Yr. CAGR %	-	55.66	40.95	14	-24.79
Total Assets, 2 Yr. CAGR %	-	104.7	-27.59	-65.01	115.31
Tangible Book Value, 2 Yr. CAGR %	-	93.14	50.16	31.15	-53.03
Common Equity, 2 Yr. CAGR %	-	93.14	50.16	31.15	-53.03
Cash From Operations, 2 Yr. CAGR %	-	66.78	111.12	-71.71	25.14
Capital Expenditures, 2 Yr. CAGR %	-	-	20.9	-6.34	-45.64
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	521.18	-53.96	-50.12
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	584.4	-53.49	-50.26
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	7.43	-16.18	5.64
Gross Profit, 3 Yr. CAGR %	-	-	-15.55	35.32	11.72
EBITDA, 3 Yr. CAGR %	-	-	41.95	52.43	-5.56
EBITA, 3 Yr. CAGR %	-	-	41.88	52.46	-5.42
EBIT, 3 Yr. CAGR %	-	-	41.88	52.46	-5.42
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	101.85	51.02	-23.39
Net Income, 3 Yr. CAGR %	-	-	101.85	51.02	-23.39
Normalized Net Income, 3 Yr. CAGR %	-	-	60.78	51.01	4.08
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-19.05	-64.16
Accounts Receivable, 3 Yr. CAGR %	-	-	-8.1	32.42	196.58
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	42.32	29.47	-12.33
Total Assets, 3 Yr. CAGR %	-	-	12.19	61.61	-58.65
Tangible Book Value, 3 Yr. CAGR %	-	-	65.05	40.89	-31.62
Common Equity, 3 Yr. CAGR %	-	-	65.05	40.89	-31.62
Cash From Operations, 3 Yr. CAGR %	-	-	56.98	55.86	-55.86
Capital Expenditures, 3 Yr. CAGR %	-	-	-	19.43	-39.3
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	112.34	-38.59
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	126.27	-38.55
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	10.52
Gross Profit, 5 Yr. CAGR %	-	-	-	-	18.82
EBITDA, 5 Yr. CAGR %	-	-	-	-	26.9
EBITA, 5 Yr. CAGR %	-	-	-	-	26.95
EBIT, 5 Yr. CAGR %	-	-	-	-	26.95
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	-0.15
Net Income, 5 Yr. CAGR %	-	-	-	-	-0.15
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	22.2
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	20.43
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	10.3
Total Assets, 5 Yr. CAGR %	-	-	-	-	45.67
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	0.72
Common Equity, 5 Yr. CAGR %	-	-	-	-	0.72
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	28.7